TAAV Biomanufacturing Solutions is advancing gene therapy by offering its synthetic, linear, double stranded DNA, dbDNA, as the new industry standard for transfection-based AAV production. We believe it is a safer, more effective, more scalable and a faster way to manufacture AAV.